3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
8
Completed
5
Unknown
2
Terminated
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
8
Neoplasms
7
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Neoplastic Cells, Circulating
2
Melanoma
2
Lung Diseases
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
von Hippel-Lindau Disease
1
Weight Loss
1
Uterine Cervical Neoplasms
1
Sleep Apnea Syndromes
1
Skin Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Ovarian Insufficiency
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Nervous System Diseases
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Interventions
Radiotherapy
11
pembrolizumab
10
Nivolumab
10
Doxorubicin
10
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Ipilimumab
7
Cyclophosphamide
7
Biopsy
7
X-Rays
6
Radiation
5
Phantoms, Imaging
5
Ifosfamide
5
talimogene laherparepvec
4
cabozantinib
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
tazemetostat
3
selpercatinib
3
pazopanib
3
liposomal doxorubicin
3
Temozolomide
3
Etoposide
3
ulixertinib
2
tislelizumab
2
tipifarnib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Sarcoma
×
Blood Specimen Collection
×
Clear all
NCT03375437
2024-08-26
RNASARC
Centre Leon Berard
Phase NA
Active not recruiting
376 enrolled